Register now for this free webinar from Xtalks: Current and Emerging Biomarkers to Advance Clinical Research in Parkinson’s Disease.
The live Xtalks webinar will take place Monday, September 12, 2022, at 11am EDT (4pm BST/UK). Participants include Robert Martone, Associate Director, Neurology Biomarkers, Biomarkers Solution Center, Labcorp Drug Development; Hiba Kazmi, PhD, Biomarker Scientist, IXICO; and Antoniya Todorova, MD, PhD, Medical Director, Labcorp.
Attendees will hear about emerging approaches for Parkinson’s disease biomarkers, such as advanced magnetic resonance imaging (MRI). The featured speakers will discuss how fluid and imaging biomarkers can impact study design and patient selection in Parkinson’s disease clinical trials.
Parkinson’s disease biomarker research continues to advance with the objectives of enabling earlier detection of neurodegeneration, elucidating disease mechanisms, identifying potential therapeutic targets as well as monitoring disease progression. While many promising biomarkers have been proposed, the ideal biomarker — with adequate sensitivity or specificity — remains elusive.
From α-synuclein to advanced magnetic resonance imaging (MRI) techniques, this webinar will cover both traditional Parkinson’s disease biomarkers and the potential utility of emerging biomarkers, such as microRNA (miRNA), microbiome and multimodal approaches.
Citing longitudinal research studies and recent clinical trials, the featured speakers will share the potential utility of fluid-based biomarkers and imaging biomarkers, discussing how each may help track drug efficacy and advance clinical trials.
[Source(s): Xtalks, PRWeb]
